ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RVMD Revolution Medicines Inc

39.54
2.16 (5.78%)
Last Updated: 04:24:31
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 7.58M9.12M3.36M15.33M7.01M3.82M0742k
Operating Income -57.95M-62.09M-76.53M-61.71M-75.16M-108.8M-123.25M-179.98M
Pre Tax Income -57.65M-61.22M-73.63M-56.63M-68.1M-98.3M-112.3M-161.19M
Net Income -57.65M-61.22M-73.33M-56.51M-68.1M-98.3M-108.43M-161.54M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -57.95M-62.09M-76.53M-61.71M-75.16M-108.8M-123.25M-179.98M
EBITDA -56.78M-60.89M-75.28M-60.29M-73.69M-107.31M-121.71M-178.37M
Year End 31 December 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 020.17M50.04M42.98M29.39M35.38M11.58M
Operating Income -31.13M-40.33M-54.12M-110.7M-188.01M-258.28M-487.19M
Pre Tax Income -31.13M-41.79M-52.04M-108.53M-187.09M-249.13M-439.89M
Net Income -34.89M-48.82M-61.9M-110.38M-187.09M-248.71M-436.37M
Preferred Dividends -3.76M-7.03M-14.24M-2.22M000
Basic Earnings Per Share (EPS) -2.682-3.126-18.804-1.657-2.523-2.751-3.983
EBIT -31.13M-42.45M-54.12M-110.7M-188.01M-258.28M-487.19M
EBITDA -29.94M-38.57M-50.78M-107.02M-183.84M-253.24M-481.08M